The Effect of Combined Treatment With Sodium Phenylbutyrate and Cisplatin, Erlotinib, or Gefitinib on Resistant NSCLC Cells

Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s174074
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa UK Limited

Related search

Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

PLoS ONE
Multidisciplinary
2013English

Shikonin Sensitizes Wild‑type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Interactive Effect of Heat Treatment Combined With Cisplatin (CDDP) or Mitomycin C (MMC) on Human Gingival Carcinoma Cells

Practica Otologica, Supplement
Otorhinolaryngology
1993English

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

Clinical Cancer Research
Cancer ResearchOncology
2007English

Apoptotic Effect of Cordycepin Combined With Cisplatin and/or Paclitaxel on MA-10 Mouse Leydig Tumor Cells

OncoTargets and Therapy
OncologyPharmacology
2015English

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells With MET Amplification

PLoS ONE
Multidisciplinary
2013English

Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy